Real-World Performance of Susceptibility Testing for Ceftolozane/Tazobactam against Non-Carbapenemase-Producing Carbapenem-Resistant Pseudomonas aeruginosa
Journal
Antimicrobial Agents and Chemotherapy
ISSN
0066-4804
1098-6596
Date Issued
2022
Author(s)
Manuel Alcalde-Rico
José R. W. Martínez
María Victoria Moreno
Pamela Rojas
Aniela Wozniak
Patricia García
Jorge Olivares-Pacheco
William R. Miller
Cesar A. Arias
Ayesha Khan
Type
Resource Types::text::journal::journal article
DOI
URL
Abstract
<jats:p> Ceftolozane/tazbactam (C/T) is a potent anti-pseudomonal agent that has clinical utility against infections caused by non-carbapenemase, producing-carbapenem-resistant <jats:named-content content-type="genus-species">Pseudomonas aeruginosa</jats:named-content> (non-CP-CR-PA). Accurate, precise, and reliable antimicrobial susceptibility testing (AST) is crucial to guide clinical decisions. </jats:p>